A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial

Donald E Cutlip, Martin B Leon, Kalon KL Ho, Paul C Gordon, Alessandro Giambartolomei, Daniel J Diver, David M Lasorda, David O Williams, Michelle M Fitzpatrick, April Desjardin, Jeffrey J Popma, Richard E Kuntz, Donald S Baim, STent Anti-thrombotic Regimen Study Investigators, Acute and nine-month clinical outcomes after "suboptimal" coronary stenting: results from the STent Anti-thrombotic Regimen Study (STARS) registry. Journal of the American College of Cardiology. ,vol. 34, pp. 698- 706 ,(1999) , 10.1016/S0735-1097(99)00271-5

The thrombolysis in myocardial infarction (TIMI) trial. The New England Journal of Medicine. ,vol. 313, pp. 1018- ,(1985) , 10.1056/NEJM198510173131611

Lars Wallentin, Eva Swahn, Long-term low-molecular-mass heparin in unstable coronary-artery disease : FRISC II prospective randomised multicentre study. The Lancet. ,vol. 345, pp. 701- 707 ,(1999)

G von der Lippe, L Wikstrom, IM Andersen, T Toftegaard-Nielsen, G Alsjo, J Kyst-Madsen, E Stahle, M Bertrand, E Svensson, GP Eriksson, H Wedel, M Gulin, SY Hassan, H Pilegaard, J Nordrehaug, B Lindvall, TT Nielsen, KA Jacobsson, S Persson, P Abrahamsson, A Holmgren, P Grande, G Lindstrom, E Stahl, T Seim, JE Nordrehaug, JD Nielsen, D Julian, G Setterberg, J Hulting, K Radegran, D Lindblom, M Arbeus, SL Ekstrom, H Saetre, O Geiran, T Jernberg, G Stenport, H Ohlin, H Bylund, G Frostfeldt, I Sjogren, A Rollag, B Andren, R Svedjeholm, T Kellerth, B Svane, L Wallentin, M Janzon, B Lindahl, S Husted, U Naslund, F Kontny, E Logander, E Swahn, B Lagerqvist, K Thygesen, E Diderholm, A Siegbahn, P Venge, M Dellborg, Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators The Lancet. ,vol. 354, pp. 701- 707 ,(1999)

F Ragmin, Fast Revascularisation during InStability in Coronary artery disease (FRISC II) Investigators, None, Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study The Lancet. ,vol. 354, pp. 708- 715 ,(1999) , 10.1016/S0140-6736(99)07349-3

Franz-Josef Neumann, Meinrad Gawaz, Ilka Ott, Andreas May, Georg Mössmer, Albert Schömig, Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary palmaz-schatz stenting Journal of the American College of Cardiology. ,vol. 27, pp. 15- 21 ,(1996) , 10.1016/0735-1097(95)00433-5

Marie C. Morice, Gilles Zemour, Edgar Benveniste, Yves Biron, Claude Bourdonnec, René Faivre, Jean Fajadet, Philippe Gaspard, Bernard Glatt, Patrick Joly, Pierre Labrunie, Yves Lienhart, Jean Marco, Pierre Y. Petiteau, Thierry Royer, Bernard Valeix, Intracoronary stenting without coumadin: one month results of a French multicenter study. Catheterization and Cardiovascular Diagnosis. ,vol. 35, pp. 1- 7 ,(1995) , 10.1002/CCD.1810350102

Richard A. Schatz, Sheldon Goldberg, Martin Leon, Donald Baim, John Hirshfeld, Michael Cleman, Stephen Ellis, Eric Topol, Clinical experience with the Palmaz-Schatz coronary stent. Journal of the American College of Cardiology. ,vol. 17, pp. 155- 159 ,(1991) , 10.1016/0735-1097(91)90952-6

Koon-Hou Mak, Guido Belli, Stephen G. Ellis, David J. Moliterno, Subacute stent thrombosis: Evolving issues and current concepts Journal of the American College of Cardiology. ,vol. 27, pp. 494- 503 ,(1996) , 10.1016/0735-1097(95)00466-1

James N. Huang, Akiko Shimamura, LOW-MOLECULAR-WEIGHT HEPARINS Hematology-oncology Clinics of North America. ,vol. 12, pp. 1251- 1281 ,(1998) , 10.1016/S0889-8588(05)70052-6